KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Retained Earnings (2016 - 2026)

West Pharmaceutical Services has reported Retained Earnings over the past 18 years, most recently at $4.5 billion for Q1 2026.

  • Quarterly Retained Earnings rose 11.03% to $4.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 billion through Mar 2026, up 11.03% year-over-year, with the annual reading at -$105.5 million for FY2025, 59.12% up from the prior year.
  • Retained Earnings was $4.5 billion for Q1 2026 at West Pharmaceutical Services, up from -$105.5 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $4.5 billion in Q1 2026 and troughed at -$258.1 million in Q4 2024.
  • The 5-year median for Retained Earnings is -$102.3 million (2025), against an average of $1.6 billion.
  • Biggest five-year swings in Retained Earnings: crashed 111.38% in 2022 and later soared 2196.31% in 2025.
  • Tracing WST's Retained Earnings over 5 years: stood at $3.0 billion in 2022, then plummeted by 104.81% to -$143.8 million in 2023, then plummeted by 79.49% to -$258.1 million in 2024, then surged by 59.12% to -$105.5 million in 2025, then skyrocketed by 4342.56% to $4.5 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $4.5 billion, -$105.5 million, and -$102.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.